Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Report

Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：155
  • REPORT CODE：GMM848387
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs market report explains the definition, types, applications, major countries, and major players of the Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Heron Therapeutics

    • Merck & Co Inc

    • Tesaro

    • Helsinn Group

    • GlaxoSmithKline Plc

    By Type:

    • Corticosteroids

    • Serotonin Antagonists

    • Dopamine Antagonists

    • NK-1 Inhibitors

    • Cannabinoids

    • Motion Sickness Treatments

    • Anti-Anxiety Drugs

    • Other

    By End-User:

    • High Emetic Risk Intravenous Chemotherapy

    • Moderate Emetic Risk Intravenous Chemotherapy

    • Low and Minimal Emetic Risk Intravenous Chemotherapy

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Outlook to 2028- Original Forecasts

    • 2.2 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market- Recent Developments

    • 6.1 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market News and Developments

    • 6.2 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Deals Landscape

    7 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Raw Materials and Cost Structure Analysis

    • 7.1 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Key Raw Materials

    • 7.2 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Price Trend of Key Raw Materials

    • 7.3 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Key Suppliers of Raw Materials

    • 7.4 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Concentration Rate of Raw Materials

    • 7.5 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Cost Structure Analysis

      • 7.5.1 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Raw Materials Analysis

      • 7.5.2 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Labor Cost Analysis

      • 7.5.3 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Expenses Analysis

    8 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Export by Region (Top 10 Countries) (2017-2028)

    9 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Corticosteroids Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Serotonin Antagonists Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Dopamine Antagonists Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global NK-1 Inhibitors Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Cannabinoids Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Motion Sickness Treatments Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Anti-Anxiety Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global High Emetic Risk Intravenous Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Moderate Emetic Risk Intravenous Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Low and Minimal Emetic Risk Intravenous Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Analysis and Outlook till 2022

    • 10.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.2.2 Canada Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.2.3 Mexico Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.3.2 UK Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.3.3 Spain Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.3.4 Belgium Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.3.5 France Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.3.6 Italy Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.3.7 Denmark Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.3.8 Finland Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.3.9 Norway Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.3.10 Sweden Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.3.11 Poland Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.3.12 Russia Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.3.13 Turkey Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.4.2 Japan Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.4.3 India Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.4.4 South Korea Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.4.5 Pakistan Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.4.6 Bangladesh Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.4.7 Indonesia Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.4.8 Thailand Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.4.9 Singapore Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.4.10 Malaysia Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.4.11 Philippines Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.4.12 Vietnam Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.5.2 Colombia Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.5.3 Chile Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.5.4 Argentina Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.5.5 Venezuela Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.5.6 Peru Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.5.7 Puerto Rico Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.5.8 Ecuador Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.6.2 Kuwait Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.6.3 Oman Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.6.4 Qatar Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.7.2 South Africa Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.7.3 Egypt Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.7.4 Algeria Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.8.2 New Zealand Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

    11 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Competitive Analysis

    • 11.1 Heron Therapeutics

      • 11.1.1 Heron Therapeutics Company Details

      • 11.1.2 Heron Therapeutics Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Heron Therapeutics Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

      • 11.1.4 Heron Therapeutics Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Merck & Co Inc

      • 11.2.1 Merck & Co Inc Company Details

      • 11.2.2 Merck & Co Inc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Merck & Co Inc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

      • 11.2.4 Merck & Co Inc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Tesaro

      • 11.3.1 Tesaro Company Details

      • 11.3.2 Tesaro Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Tesaro Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

      • 11.3.4 Tesaro Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Helsinn Group

      • 11.4.1 Helsinn Group Company Details

      • 11.4.2 Helsinn Group Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Helsinn Group Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

      • 11.4.4 Helsinn Group Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 GlaxoSmithKline Plc

      • 11.5.1 GlaxoSmithKline Plc Company Details

      • 11.5.2 GlaxoSmithKline Plc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 GlaxoSmithKline Plc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

      • 11.5.4 GlaxoSmithKline Plc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    12 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Outlook by Types and Applications to 2028

    • 12.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Serotonin Antagonists Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Dopamine Antagonists Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global NK-1 Inhibitors Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Cannabinoids Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Motion Sickness Treatments Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.7 Global Anti-Anxiety Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.8 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global High Emetic Risk Intravenous Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Moderate Emetic Risk Intravenous Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Low and Minimal Emetic Risk Intravenous Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Analysis and Outlook to 2028

    • 13.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.2.2 Canada Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.3.2 UK Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.3.3 Spain Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.3.5 France Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.3.6 Italy Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.3.8 Finland Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.3.9 Norway Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.3.11 Poland Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.3.12 Russia Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.4.2 Japan Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.4.3 India Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.5.3 Chile Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.5.6 Peru Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.6.3 Oman Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs

    • Figure of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Picture

    • Table Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Corticosteroids Consumption and Growth Rate (2017-2022)

    • Figure Global Serotonin Antagonists Consumption and Growth Rate (2017-2022)

    • Figure Global Dopamine Antagonists Consumption and Growth Rate (2017-2022)

    • Figure Global NK-1 Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global Cannabinoids Consumption and Growth Rate (2017-2022)

    • Figure Global Motion Sickness Treatments Consumption and Growth Rate (2017-2022)

    • Figure Global Anti-Anxiety Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global High Emetic Risk Intravenous Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Moderate Emetic Risk Intravenous Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Low and Minimal Emetic Risk Intravenous Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption by Country (2017-2022)

    • Table North America Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption by Country (2017-2022)

    • Figure United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Canada Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Mexico Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption by Country (2017-2022)

    • Figure Germany Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure UK Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Spain Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Belgium Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure France Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Italy Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Denmark Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Finland Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Norway Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Sweden Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Poland Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Russia Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Turkey Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Table APAC Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption by Country (2017-2022)

    • Figure China Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Thailand Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Singapore Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Philippines Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Table South America Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption by Country (2017-2022)

    • Figure Brazil Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Colombia Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Chile Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Argentina Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Peru Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Table GCC Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption by Country (2017-2022)

    • Figure Bahrain Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Oman Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Qatar Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Table Africa Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption by Country (2017-2022)

    • Figure Nigeria Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Africa Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Egypt Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Algeria Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Table Oceania Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption by Country (2017-2022)

    • Figure Australia Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Table Heron Therapeutics Company Details

    • Table Heron Therapeutics Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Heron Therapeutics Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

    • Table Heron Therapeutics Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

    • Table Merck & Co Inc Company Details

    • Table Merck & Co Inc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co Inc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

    • Table Merck & Co Inc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

    • Table Tesaro Company Details

    • Table Tesaro Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tesaro Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

    • Table Tesaro Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

    • Table Helsinn Group Company Details

    • Table Helsinn Group Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Helsinn Group Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

    • Table Helsinn Group Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

    • Table GlaxoSmithKline Plc Company Details

    • Table GlaxoSmithKline Plc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Plc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

    • Table GlaxoSmithKline Plc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

    • Figure Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Serotonin Antagonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dopamine Antagonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global NK-1 Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cannabinoids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Motion Sickness Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anti-Anxiety Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global High Emetic Risk Intravenous Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Moderate Emetic Risk Intravenous Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Low and Minimal Emetic Risk Intravenous Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast by Country (2022-2028)

    • Table North America Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast by Country (2022-2028)

    • Figure Germany Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast by Country (2022-2028)

    • Figure China Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast by Country (2022-2028)

    • Figure Brazil Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast by Country (2022-2028)

    • Figure Australia Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US